Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	HSPG2 CLSTN3 CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7 CLSTN2 PPEF2 PLA2G4D SYT10 RYR1 RYR2 RYR3 ITPR2 SLC8A1 CDK5R1 HMCN2 ANKEF1 LRP2 EDEM1 PLS3	1.22e-07	749	185	24	GO:0005509
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	RASA3 RYR1 RYR2 RYR3 ITPR2	5.02e-07	18	185	5	GO:0015278
GeneOntologyMolecularFunction	coumarin 7-hydroxylase activity	CYP2A6 CYP2A7 CYP2A13	7.83e-07	3	185	3	GO:0008389
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR2 RYR3	3.11e-06	4	185	3	GO:0005219
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	RASA3 RYR1 RYR2 RYR3 ITPR2	9.04e-06	31	185	5	GO:0099604
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	RASA3 RYR1 RYR2 RYR3 ITPR2	1.24e-05	33	185	5	GO:0005217
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR2 RYR3	1.53e-05	6	185	3	GO:0048763
GeneOntologyMolecularFunction	X11-like protein binding	CLSTN3 CLSTN2	2.55e-04	3	185	2	GO:0042988
GeneOntologyMolecularFunction	calmodulin binding	MYO1G MYO1D RYR1 RYR2 RYR3 SLC8A1 MYO15A SNTA1 SNTB2	3.04e-04	230	185	9	GO:0005516
GeneOntologyMolecularFunction	microfilament motor activity	MYO1G MYO1D MYO19 MYO15A	4.12e-04	38	185	4	GO:0000146
GeneOntologyMolecularFunction	DNA endonuclease activity	APEX1 XRCC3 FAN1 N4BP2	7.25e-04	44	185	4	GO:0004520
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO1G DNHD1 MYO1D MYO19 DNAH14 MYO15A	8.15e-04	118	185	6	GO:0003774
GeneOntologyMolecularFunction	phosphodiesterase I activity	APEX1 FAN1	8.38e-04	5	185	2	GO:0004528
GeneOntologyBiologicalProcess	cellular response to caffeine	RYR1 RYR2 RYR3 SLC8A1	1.97e-06	11	185	4	GO:0071313
GeneOntologyBiologicalProcess	cellular response to purine-containing compound	RYR1 RYR2 RYR3 SLC8A1	5.85e-06	14	185	4	GO:0071415
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CLSTN3 CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7 CLSTN2 HMCN2	7.57e-06	187	185	10	GO:0007156
GeneOntologyBiologicalProcess	intracellular transport	SMG1 CLTCL1 HDAC6 IPO8 IPO7 ACD MYO1D COPA UACA ZFYVE16 VPS13C MYO19 VTA1 BLOC1S1 COG3 ANKRD50 DTNBP1 ASB15 TRAK1 FBXO22 MDN1 PPP6C IER3IP1 TBC1D14 VPS13A LRP2 HERC2 EDEM1 CLEC16A GOLGA2 VPS13B	1.01e-05	1496	185	31	GO:0046907
GeneOntologyBiologicalProcess	neuron projection morphogenesis	BOC HSPG2 CLSTN3 ATP7A HDAC6 ACHE LAMA1 CDKL3 PCDHAC2 CLASP2 CUL7 DTNBP1 TRAK1 CDK5R1 HMCN2 PTPRD PTPRS VPS13A LRP2 POTEJ GOLGA2	1.12e-05	802	185	21	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	BOC HSPG2 CLSTN3 ATP7A HDAC6 ACHE LAMA1 CDKL3 PCDHAC2 CLASP2 CUL7 DTNBP1 TRAK1 CDK5R1 HMCN2 PTPRD PTPRS VPS13A LRP2 POTEJ GOLGA2	1.54e-05	819	185	21	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	BOC HSPG2 CLSTN3 ATP7A HDAC6 ACHE LAMA1 CDKL3 PCDHAC2 CLASP2 CUL7 DTNBP1 TRAK1 CDK5R1 HMCN2 PTPRD PTPRS VPS13A LRP2 POTEJ GOLGA2	1.74e-05	826	185	21	GO:0048858
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	CLSTN3 CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7 CLSTN2 HMCN2 PTPRD PTPRS	2.72e-05	313	185	12	GO:0098742
GeneOntologyBiologicalProcess	response to caffeine	RYR1 RYR2 RYR3 SLC8A1	3.33e-05	21	185	4	GO:0031000
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	BOC HSPG2 ATP7A HDAC6 ACHE LAMA1 CDKL3 PCDHAC2 CLASP2 CUL7 DTNBP1 TRAK1 CDK5R1 HMCN2 PTPRD PTPRS LRP2 POTEJ GOLGA2	4.54e-05	748	185	19	GO:0048667
GeneOntologyBiologicalProcess	actin filament-based process	MYO1G HDAC6 MYO1D EPB41L4B MYO19 CARMIL1 CLASP2 DTNBP1 NPHP4 RYR2 KPTN CDK5R1 KASH5 DLG1 MAD2L2 POTEJ IKBKB MYO15A NLRP4 PLS3 SNTA1	7.32e-05	912	185	21	GO:0030029
GeneOntologyBiologicalProcess	dendrite morphogenesis	ATP7A HDAC6 ACHE CDKL3 CUL7 DTNBP1 TRAK1 CDK5R1 PTPRD	7.75e-05	198	185	9	GO:0048813
GeneOntologyBiologicalProcess	phenylpropanoid metabolic process	CYP2A6 CYP2A7 CYP2A13	8.13e-05	10	185	3	GO:0009698
GeneOntologyBiologicalProcess	coumarin metabolic process	CYP2A6 CYP2A7 CYP2A13	8.13e-05	10	185	3	GO:0009804
GeneOntologyBiologicalProcess	neuron projection development	BOC HSPG2 CLSTN3 ATP7A HDAC6 ACHE LAMA1 CDKL3 PCDHAC2 CLASP2 BLOC1S1 CUL7 DTNBP1 TRAK1 CDK5R1 HMCN2 PTPRD PTPRS VPS13A FBXO7 LRP2 LTK POTEJ IKBKB GOLGA2 VPS13B	8.45e-05	1285	185	26	GO:0031175
GeneOntologyBiologicalProcess	regulation of extracellular matrix organization	LEMD3 LAMA1 CLASP2 CHADL IER3IP1 MAD2L2	1.09e-04	84	185	6	GO:1903053
GeneOntologyBiologicalProcess	actin cytoskeleton organization	MYO1G HDAC6 MYO1D EPB41L4B MYO19 CARMIL1 CLASP2 DTNBP1 NPHP4 KPTN CDK5R1 KASH5 DLG1 MAD2L2 POTEJ IKBKB MYO15A NLRP4 PLS3	1.16e-04	803	185	19	GO:0030036
GeneOntologyBiologicalProcess	endosomal transport	CLTCL1 MYO1D ZFYVE16 VTA1 BLOC1S1 ANKRD50 ASB15 TBC1D14 LRP2 CLEC16A VPS13B	1.55e-04	320	185	11	GO:0016197
GeneOntologyBiologicalProcess	axonogenesis	BOC HSPG2 HDAC6 ACHE LAMA1 CDKL3 PCDHAC2 CLASP2 TRAK1 CDK5R1 HMCN2 PTPRS LRP2 POTEJ GOLGA2	1.87e-04	566	185	15	GO:0007409
GeneOntologyBiologicalProcess	positive regulation of cellular component organization	CLSTN3 ATP7A HDAC6 ACD ACHE CARMIL1 CDKL3 CLASP2 CLSTN2 CUL7 DTNBP1 NPHP4 TRAK1 CDK5R1 NCAPG PTPRD IER3IP1 FBXO7 LRP2 DLG1 LTK SHCBP1L MAD2L2 IKBKB CLEC16A GOLGA2	2.24e-04	1366	185	26	GO:0051130
GeneOntologyBiologicalProcess	neuron development	BOC HSPG2 CLSTN3 ATP7A HDAC6 ACHE LAMA1 CDKL3 PCDHAC2 CLASP2 BLOC1S1 CUL7 DTNBP1 NPHP4 TRAK1 CDK5R1 HMCN2 PTPRD PTPRS VPS13A FBXO7 LRP2 LTK POTEJ IKBKB GOLGA2 VPS13B	2.75e-04	1463	185	27	GO:0048666
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	RYR1 RYR2 RYR3 SLC8A1	3.28e-04	37	185	4	GO:0014808
GeneOntologyBiologicalProcess	positive regulation of dendrite morphogenesis	HDAC6 ACHE CDKL3 CUL7 PTPRD	3.39e-04	67	185	5	GO:0050775
GeneOntologyCellularComponent	axon	BOC ATP7A HDAC6 MYO1D COPA ACHE CLASP2 BLOC1S1 DTNBP1 TRAK1 ITPR2 SLC8A1 CDK5R1 HMCN2 PTPRS LRP2 DLG1 CTNND1 POTEJ CD200	1.03e-04	891	182	20	GO:0030424
GeneOntologyCellularComponent	growth cone	BOC COPA CLASP2 DTNBP1 TRAK1 CDK5R1 PTPRS LRP2 CTNND1	3.07e-04	245	182	9	GO:0030426
GeneOntologyCellularComponent	site of polarized growth	BOC COPA CLASP2 DTNBP1 TRAK1 CDK5R1 PTPRS LRP2 CTNND1	3.88e-04	253	182	9	GO:0030427
GeneOntologyCellularComponent	cell cortex	CNKSR1 MYO1D CLASP2 RYR1 TRAK1 ITPR2 SEPTIN3 HMCN2 INSC CTNND1 NLRP4	4.25e-04	371	182	11	GO:0005938
GeneOntologyCellularComponent	somatodendritic compartment	BOC CLSTN3 ATP7A HDAC6 MYO1D COPA ACHE RGS11 CNKSR2 CLSTN2 DTNBP1 TRAK1 SLC8A1 CDK5R1 HMCN2 PTPRS VPS13A LRP2 DLG1 CTNND1 GOLGA2 CD200 PDE11A	4.36e-04	1228	182	23	GO:0036477
GeneOntologyCellularComponent	sarcoplasm	XDH DTNBP1 RYR1 RYR2 RYR3 ITPR2	4.92e-04	114	182	6	GO:0016528
GeneOntologyCellularComponent	axonal growth cone	BOC CLASP2 TRAK1 LRP2	6.27e-04	45	182	4	GO:0044295
GeneOntologyCellularComponent	sarcoplasmic reticulum membrane	RYR1 RYR2 RYR3 ITPR2	6.27e-04	45	182	4	GO:0033017
GeneOntologyCellularComponent	smooth endoplasmic reticulum	MYO1D RYR1 RYR2 RYR3	6.82e-04	46	182	4	GO:0005790
GeneOntologyCellularComponent	cytoplasmic side of membrane	RASA3 BLOC1S1 RYR1 RYR2 RYR3 THADA DLG1 IKBKB	9.44e-04	230	182	8	GO:0098562
GeneOntologyCellularComponent	neuronal cell body	BOC ATP7A HDAC6 MYO1D COPA ACHE CNKSR2 DTNBP1 SLC8A1 CDK5R1 HMCN2 PTPRS VPS13A DLG1 GOLGA2 CD200 PDE11A	1.03e-03	835	182	17	GO:0043025
GeneOntologyCellularComponent	sarcoplasmic reticulum	XDH RYR1 RYR2 RYR3 ITPR2	1.03e-03	88	182	5	GO:0016529
GeneOntologyCellularComponent	protein phosphatase 4 complex	PPP4R3A PPP4C	1.11e-03	6	182	2	GO:0030289
GeneOntologyCellularComponent	sarcolemma	DTNBP1 RYR1 RYR2 RYR3 SLC8A1 DLG1 SNTA1	1.41e-03	190	182	7	GO:0042383
Domain	-	ANKK1 UACA ANKRD62 ANKRD20A2P ANKRD20A3P ANKRD50 ASB15 ANKRD6 ANKRD20A4P ANKEF1 ANKRD30A ANKRD28 POTEJ AGAP6 ANKRD20A1 PPP1R12C PPP1R27	6.32e-10	248	189	17	1.25.40.20
Domain	ANK	ANKK1 UACA ANKRD62 ANKRD20A2P ANKRD20A3P ANKRD50 ASB15 ANKRD6 ANKRD20A4P ANKEF1 ANKRD30A ANKRD28 POTEJ AGAP6 ANKRD20A1 PPP1R12C PPP1R27	7.60e-10	251	189	17	SM00248
Domain	ANK_REPEAT	ANKK1 UACA ANKRD62 ANKRD20A2P ANKRD20A3P ANKRD50 ASB15 ANKRD6 ANKRD20A4P ANKEF1 ANKRD30A ANKRD28 POTEJ AGAP6 ANKRD20A1 PPP1R12C PPP1R27	8.58e-10	253	189	17	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKK1 UACA ANKRD62 ANKRD20A2P ANKRD20A3P ANKRD50 ASB15 ANKRD6 ANKRD20A4P ANKEF1 ANKRD30A ANKRD28 POTEJ AGAP6 ANKRD20A1 PPP1R12C PPP1R27	9.12e-10	254	189	17	IPR020683
Domain	ANK_REP_REGION	ANKK1 UACA ANKRD62 ANKRD20A2P ANKRD20A3P ANKRD50 ASB15 ANKRD6 ANKRD20A4P ANKEF1 ANKRD30A ANKRD28 POTEJ AGAP6 ANKRD20A1 PPP1R12C PPP1R27	9.12e-10	254	189	17	PS50297
Domain	Ank	ANKK1 UACA ANKRD62 ANKRD20A2P ANKRD20A3P ANKRD50 ASB15 ANKRD6 ANKRD20A4P ANKEF1 ANKRD30A ANKRD28 POTEJ ANKRD20A1 PPP1R12C PPP1R27	1.46e-09	228	189	16	PF00023
Domain	Ankyrin_rpt	ANKK1 UACA ANKRD62 ANKRD20A2P ANKRD20A3P ANKRD50 ASB15 ANKRD6 ANKRD20A4P ANKEF1 ANKRD30A ANKRD28 POTEJ AGAP6 ANKRD20A1 PPP1R12C PPP1R27	1.46e-09	262	189	17	IPR002110
Domain	Ank_2	ANKK1 UACA ANKRD20A2P ANKRD20A3P ANKRD50 ASB15 ANKRD6 ANKRD20A4P ANKEF1 ANKRD30A ANKRD28 POTEJ AGAP6 ANKRD20A1 PPP1R12C	5.27e-09	215	189	15	PF12796
Domain	ARM-type_fold	SMG1 CLTCL1 IPO8 IPO7 MIF4GD CLASP2 CUL7 RYR3 PPP4R3A ITPR2 ARFGEF3 THADA NCAPG PIK3C2B INSC UTP20 CTNND1 EIF3M	1.12e-08	339	189	18	IPR016024
Domain	RIH_assoc-dom	RYR1 RYR2 RYR3 ITPR2	1.50e-07	6	189	4	IPR013662
Domain	Ins145_P3_rec	RYR1 RYR2 RYR3 ITPR2	1.50e-07	6	189	4	PF08709
Domain	RIH_assoc	RYR1 RYR2 RYR3 ITPR2	1.50e-07	6	189	4	PF08454
Domain	RIH_dom	RYR1 RYR2 RYR3 ITPR2	1.50e-07	6	189	4	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR2 RYR3 ITPR2	1.50e-07	6	189	4	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR2 RYR3 ITPR2	1.50e-07	6	189	4	IPR015925
Domain	-	RYR1 RYR2 RYR3 ITPR2	1.50e-07	6	189	4	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR2 RYR3 ITPR2	1.50e-07	6	189	4	PF01365
Domain	CRIC	CNKSR1 CNKSR2 CNKSR3	1.02e-06	3	189	3	PS51290
Domain	Ryanodine_rcpt	RYR1 RYR2 RYR3	1.02e-06	3	189	3	IPR003032
Domain	CRIC_domain	CNKSR1 CNKSR2 CNKSR3	1.02e-06	3	189	3	IPR017874
Domain	CRIC_ras_sig	CNKSR1 CNKSR2 CNKSR3	1.02e-06	3	189	3	PF10534
Domain	Ryanrecept_TM4-6	RYR1 RYR2 RYR3	1.02e-06	3	189	3	IPR009460
Domain	RyR	RYR1 RYR2 RYR3	1.02e-06	3	189	3	PF02026
Domain	RR_TM4-6	RYR1 RYR2 RYR3	1.02e-06	3	189	3	PF06459
Domain	Ryan_recept	RYR1 RYR2 RYR3	1.02e-06	3	189	3	IPR013333
Domain	Cadherin_tail	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	1.78e-06	37	189	6	PF15974
Domain	Cadherin_CBD	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	1.78e-06	37	189	6	IPR031904
Domain	MIR	RYR1 RYR2 RYR3 ITPR2	2.03e-06	10	189	4	PF02815
Domain	MIR_motif	RYR1 RYR2 RYR3 ITPR2	2.03e-06	10	189	4	IPR016093
Domain	MIR	RYR1 RYR2 RYR3 ITPR2	2.03e-06	10	189	4	PS50919
Domain	MIR	RYR1 RYR2 RYR3 ITPR2	2.03e-06	10	189	4	SM00472
Domain	CADHERIN_1	CLSTN3 CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7 CLSTN2	2.22e-06	113	189	9	PS00232
Domain	Cadherin	CLSTN3 CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7 CLSTN2	2.22e-06	113	189	9	PF00028
Domain	CADHERIN_2	CLSTN3 CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7 CLSTN2	2.39e-06	114	189	9	PS50268
Domain	-	CLSTN3 CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7 CLSTN2	2.39e-06	114	189	9	2.60.40.60
Domain	CA	CLSTN3 CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7 CLSTN2	2.57e-06	115	189	9	SM00112
Domain	Cadherin-like	CLSTN3 CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7 CLSTN2	2.76e-06	116	189	9	IPR015919
Domain	Cadherin	CLSTN3 CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7 CLSTN2	3.18e-06	118	189	9	IPR002126
Domain	Cyt_P450_E_grp-I_CYP2A-like	CYP2A6 CYP2A7 CYP2A13	4.05e-06	4	189	3	IPR008067
Domain	SHR-BD	VPS13C VPS13A VPS13B	4.05e-06	4	189	3	IPR009543
Domain	VPS13_C	VPS13C VPS13A VPS13B	4.05e-06	4	189	3	PF16909
Domain	VPS13_C	VPS13C VPS13A VPS13B	4.05e-06	4	189	3	IPR031645
Domain	SHR-BD	VPS13C VPS13A VPS13B	4.05e-06	4	189	3	PF06650
Domain	Autophagy-rel_C	VPS13C VPS13A VPS13B	1.00e-05	5	189	3	IPR015412
Domain	ATG_C	VPS13C VPS13A VPS13B	1.00e-05	5	189	3	PF09333
Domain	Cadherin_2	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	4.99e-05	65	189	6	PF08266
Domain	Cadherin_N	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	4.99e-05	65	189	6	IPR013164
Domain	Chorein_N	VPS13C VPS13A VPS13B	5.50e-05	8	189	3	PF12624
Domain	VPS13_N	VPS13C VPS13A VPS13B	5.50e-05	8	189	3	IPR026854
Domain	ARM-like	SMG1 IPO8 IPO7 RIPOR3 CLASP2 CUL7 PPP4R3A NCAPG INSC UTP20 CTNND1	9.96e-05	270	189	11	IPR011989
Domain	CNKSR2	CNKSR2 CNKSR3	1.02e-04	2	189	2	IPR010599
Domain	DUF1170	CNKSR2 CNKSR3	1.02e-04	2	189	2	PF06663
Domain	Cadherin_CS	CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	1.21e-04	109	189	7	IPR020894
Domain	-	CNKSR1 GIPC2 FRMPD2 CNKSR2 CNKSR3 DLG1 SNTA1 SNTB2	1.47e-04	150	189	8	2.30.42.10
Domain	PDZ	CNKSR1 GIPC2 FRMPD2 CNKSR2 CNKSR3 DLG1 SNTA1 SNTB2	1.54e-04	151	189	8	PS50106
Domain	PDZ	CNKSR1 GIPC2 FRMPD2 CNKSR2 CNKSR3 DLG1 SNTA1 SNTB2	1.61e-04	152	189	8	IPR001478
Domain	PP2Ac	PPEF2 PPP4C PPP6C	2.71e-04	13	189	3	SM00156
Domain	Ser/Thr-sp_prot-phosphatase	PPEF2 PPP4C PPP6C	2.71e-04	13	189	3	IPR006186
Domain	SER_THR_PHOSPHATASE	PPEF2 PPP4C PPP6C	2.71e-04	13	189	3	PS00125
Domain	Cul7	CUL7 HERC2	3.04e-04	3	189	2	PF11515
Domain	Calsyntenin	CLSTN3 CLSTN2	3.04e-04	3	189	2	IPR026914
Domain	Cse1	IPO8 IPO7	3.04e-04	3	189	2	PF08506
Domain	CPH_domain	CUL7 HERC2	3.04e-04	3	189	2	IPR021097
Domain	VPS13	VPS13C VPS13A	3.04e-04	3	189	2	IPR026847
Domain	Cse1	IPO8 IPO7	3.04e-04	3	189	2	IPR013713
Domain	VPS13_mid_rpt	VPS13C VPS13A	3.04e-04	3	189	2	PF16910
Domain	VPS13	VPS13C VPS13A	3.04e-04	3	189	2	PF16908
Domain	VPS13_N2	VPS13C VPS13A	3.04e-04	3	189	2	IPR031646
Domain	VPS13_mid_rpt	VPS13C VPS13A	3.04e-04	3	189	2	IPR031642
Domain	-	IPO8 IPO7 RIPOR3 CLASP2 CUL7 NCAPG INSC UTP20 CTNND1	4.44e-04	222	189	9	1.25.10.10
Domain	Myosin_head_motor_dom	MYO1G MYO1D MYO19 MYO15A	5.73e-04	38	189	4	IPR001609
Domain	MYOSIN_MOTOR	MYO1G MYO1D MYO19 MYO15A	5.73e-04	38	189	4	PS51456
Domain	Myosin_head	MYO1G MYO1D MYO19 MYO15A	5.73e-04	38	189	4	PF00063
Domain	MYSc	MYO1G MYO1D MYO19 MYO15A	5.73e-04	38	189	4	SM00242
Domain	PDZ	GIPC2 FRMPD2 CNKSR2 CNKSR3 DLG1 SNTA1 SNTB2	5.87e-04	141	189	7	PF00595
Domain	PDZ	GIPC2 FRMPD2 CNKSR2 CNKSR3 DLG1 SNTA1 SNTB2	7.83e-04	148	189	7	SM00228
Domain	Cadherin_C	PCDHA9 PCDHGB2 PCDHAC2 PCDHA7	8.42e-04	42	189	4	IPR032455
Domain	Cadherin_C_2	PCDHA9 PCDHGB2 PCDHAC2 PCDHA7	8.42e-04	42	189	4	PF16492
Domain	2Fe2S_fd_BS	RNF186 XDH	9.98e-04	5	189	2	IPR006058
Domain	Syntrophin	SNTA1 SNTB2	9.98e-04	5	189	2	IPR015482
Domain	2FE2S_FER_1	RNF186 XDH	9.98e-04	5	189	2	PS00197
Domain	IQ	MYO1D MYO19 PPEF2 LRRIQ1 MYO15A	1.38e-03	81	189	5	SM00015
Domain	ConA-like_dom	HSPG2 CLSTN3 LAMA1 CLSTN2 RYR1 RYR2 RYR3 COL24A1	1.78e-03	219	189	8	IPR013320
Domain	APC_su10/DOC_dom	CUL7 HERC2	2.07e-03	7	189	2	IPR004939
Domain	DOC	CUL7 HERC2	2.07e-03	7	189	2	PS51284
Domain	ANAPC10	CUL7 HERC2	2.07e-03	7	189	2	PF03256
Domain	Myosin_TH1	MYO1G MYO1D	2.07e-03	7	189	2	PF06017
Domain	Myosin_TH1	MYO1G MYO1D	2.07e-03	7	189	2	IPR010926
Domain	TH1	MYO1G MYO1D	2.07e-03	7	189	2	PS51757
Domain	APC10	CUL7 HERC2	2.07e-03	7	189	2	SM01337
Domain	IQ_motif_EF-hand-BS	MYO1D MYO19 PPEF2 LRRIQ1 MYO15A	2.21e-03	90	189	5	IPR000048
Domain	LRR_6	NLRP11 CARMIL1 FBXL20 NLRP4	2.32e-03	55	189	4	PF13516
Domain	IQ	MYO1D MYO19 PPEF2 LRRIQ1 MYO15A	2.55e-03	93	189	5	PS50096
Domain	LAMININ_IVA	HSPG2 LAMA1	2.74e-03	8	189	2	PS51115
Domain	Laminin_B	HSPG2 LAMA1	2.74e-03	8	189	2	PF00052
Domain	LamB	HSPG2 LAMA1	2.74e-03	8	189	2	SM00281
Domain	Laminin_IV	HSPG2 LAMA1	2.74e-03	8	189	2	IPR000034
Domain	Metallophos	PPEF2 PPP4C PPP6C	2.77e-03	28	189	3	PF00149
Domain	Calcineurin-like_PHP_ApaH	PPEF2 PPP4C PPP6C	2.77e-03	28	189	3	IPR004843
Domain	-	HSPG2 CLSTN3 LAMA1 CLSTN2 COL24A1	2.80e-03	95	189	5	2.60.120.200
Pathway	KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY	RYR1 RYR2 RYR3 ITPR2	1.75e-05	19	120	4	M47760
Pathway	REACTOME_ION_HOMEOSTASIS	RYR1 RYR2 RYR3 ITPR2 SLC8A1	9.32e-05	54	120	5	M27460
Pathway	REACTOME_ION_HOMEOSTASIS	RYR1 RYR2 RYR3 ITPR2 SLC8A1	9.32e-05	54	120	5	MM15202
Pathway	REACTOME_CYP2E1_REACTIONS	CYP2A6 CYP2A7 CYP2A13	9.44e-05	11	120	3	M27130
Pathway	KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY	RYR1 RYR2 RYR3	9.44e-05	11	120	3	M47958
Pathway	REACTOME_CYP2E1_REACTIONS	CYP2A6 CYP2A7 CYP2A13	1.25e-04	12	120	3	MM14847
Pathway	WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING	RYR1 RYR2 RYR3	1.62e-04	13	120	3	M39589
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	IPO7 MYO1D COPA ZFYVE16 LEMD3 RNF213 CLASP2 CUL7 PPEF2 DTNBP1 PPP4R3A FAN1 ITPR2 GLMN NCAPG PPP4C PTPRD PPP6C SBF1 PTPRS VPS13A UBR3 DLG1 ANKRD28 HERC2 CTNND1 SNTB2 PPP1R12C	5.21e-12	1049	191	28	27880917
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	SMG1 COG2 CLTCL1 IPO8 IPO7 COPA UACA HDHD5 MYO19 FARSB RNF213 COG3 RFC4 ITPR2 ARFGEF3 GLMN THADA NCAPG PPP4C MDN1 PPP6C EIF2B3 GEMIN4 ANKRD28 TRMT1L IKBKB SNRNP200 PLS3 EIF3M TMEM255A	3.56e-10	1440	191	30	30833792
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	3.14e-09	24	191	6	24698270
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	RYR1 RYR2 RYR3 ITPR2	1.31e-08	6	191	4	23463619
Pubmed	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	RYR1 RYR2 RYR3 ITPR2	1.31e-08	6	191	4	25966694
Pubmed	A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.	RYR1 RYR2 RYR3 ITPR2	1.31e-08	6	191	4	20519450
Pubmed	IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.	RYR1 RYR2 RYR3 ITPR2	1.31e-08	6	191	4	16844763
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHA9 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	1.36e-08	15	191	5	15640798
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHA9 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	2.78e-08	17	191	5	29911975
Pubmed	Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex.	RYR1 RYR2 RYR3 ITPR2	3.05e-08	7	191	4	11860456
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHA9 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	3.83e-08	18	191	5	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHA9 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	3.83e-08	18	191	5	10662547
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	RYR1 RYR2 RYR3 ITPR2	6.06e-08	8	191	4	19033399
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	IPO8 IPO7 ZFYVE16 LEMD3 MCC FARSB ANKRD50 PPP4R3A FBXO22 PTPRD SBF1 PTPRS EIF2B3 GEMIN4 DLG1 ANKRD28 EDEM1 SNRNP200 PLS3 SNTA1 SNTB2	1.11e-07	974	191	21	28675297
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	COG2 ATP7A ZFYVE16 LEMD3 VPS13C BLOC1S1 COG3 ANKRD50 ITPR2 ARFGEF3 VPS13A LRP2 CTNND1 GOLGA2 VPS13B	1.47e-07	504	191	15	34432599
Pubmed	Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	31645370
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	18403125
Pubmed	A trans-acting locus regulates transcriptional repression of the female-specific steroid 15 alpha-hydroxylase gene in male mice.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	8297477
Pubmed	Lack of the steroid 15 alpha-hydroxylase gene (Cyp2a-4) in wild mouse strain Mus spretus: rapid evolution of the P450 gene superfamily.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	8188299
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	7876312
Pubmed	Comparison of hamster and mouse reveals interspecies differences in the regulation of hepatic CYP2A isozymes.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	8250953
Pubmed	The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	2703500
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	22948152
Pubmed	Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	22217847
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	10788707
Pubmed	Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	22890016
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	7621815
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	10473538
Pubmed	Reciprocal regulation of sex-dependent expression of testosterone 15 alpha-hydroxylase (P-450(15 alpha)) in liver and kidney of male mice by androgen. Evidence for a single gene.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	3346244
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	18434746
Pubmed	Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	2733794
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR1 RYR2 RYR3	1.63e-07	3	191	3	9204703
Pubmed	Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	8484736
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	21881589
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR1 RYR2 RYR3	1.63e-07	3	191	3	12213830
Pubmed	Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	1417950
Pubmed	Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	24045421
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	9242641
Pubmed	Highly homologous mouse Cyp2a4 and Cyp2a5 genes are differentially expressed in the liver and both express long non-coding antisense RNAs.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	32987105
Pubmed	Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	2765478
Pubmed	Sexual dimorphism of testosterone 15 alpha-hydroxylase mRNA levels in mouse liver. cDNA cloning and regulation.	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	191	3	2415518
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	25239916
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	18643873
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR1 RYR2 RYR3	1.63e-07	3	191	3	11159936
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	7959768
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	4600883
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR1 RYR2 RYR3	1.63e-07	3	191	3	7635066
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	MYO1D COPA EPB41L4B LAMA1 CUL7 ARFGEF3 PTPRS GEMIN4 HERC2 CTNND1 SNRNP200 SNTB2	1.89e-07	313	191	12	38270169
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	CDH26 PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	2.35e-07	77	191	7	10835267
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA9 PCDHA13 PCDHA10 PCDHA7	2.82e-07	11	191	4	9655502
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA9 PCDHGB2 PCDHA13 PCDHA10 PCDHA7	4.20e-07	28	191	5	15347688
Pubmed	New molecular components supporting ryanodine receptor-mediated Ca(2+) release: roles of junctophilin and TRIC channel in embryonic cardiomyocytes.	RYR1 RYR2 RYR3 SLC8A1	4.22e-07	12	191	4	19095005
Pubmed	Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP.	CYP2A6 CYP2A7 CYP2A13	6.50e-07	4	191	3	10490589
Pubmed	Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice.	CYP2A6 CYP2A7 CYP2A13	6.50e-07	4	191	3	1970547
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR1 RYR2 RYR3	6.50e-07	4	191	3	23413940
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR1 RYR2 RYR3	6.50e-07	4	191	3	9607712
Pubmed	Hypoxia differently modulates gene expression of inositol 1,4,5-trisphosphate receptors in mouse kidney and HEK 293 cell line.	RYR1 RYR2 ITPR2	6.50e-07	4	191	3	19120137
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR1 RYR2 RYR3	6.50e-07	4	191	3	23482488
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR1 RYR2 RYR3	6.50e-07	4	191	3	18206662
Pubmed	Transcriptional regulation by HNF-4 of the steroid 15alpha-hydroxylase P450 (Cyp2a-4) gene in mouse liver.	CYP2A6 CYP2A7 CYP2A13	6.50e-07	4	191	3	9408084
Pubmed	Analysis of the human VPS13 gene family.	VPS13C VPS13A VPS13B	6.50e-07	4	191	3	15498460
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR1 RYR2 RYR3	6.50e-07	4	191	3	9384575
Pubmed	A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.	CYP2A6 CYP2A7 CYP2A13	6.50e-07	4	191	3	7565685
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	7.29e-07	57	191	6	32633719
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	EPB41L4B ZNF618 VPS13C MYO19 LAMA1 RNF213 ANKRD20A3P DNAH14 RYR1 ITPR2 MDN1 TBC1D14 VPS13A LRP2 UTP20 ATIC SNRNP200	7.55e-07	736	191	17	29676528
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	8.09e-07	58	191	6	30377227
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 CLTCL1 RASA3 CLASP2 MED13L NPHP4 RYR1 TRAK1 ITPR2 FZD7 CDK5R1 THADA MDN1 SBF1 PIK3C2B PTPRS EIF2B3 HMGXB3 LTK HERC2 HR	8.67e-07	1105	191	21	35748872
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	COG2 HDAC6 IPO8 HDHD5 TRMT112 MYO19 XRCC3 GLMN MDN1 CNKSR3 VPS13A ANKRD28 HERC2 CTNND1 CLEC16A	1.49e-06	606	191	15	36538041
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ATP7A EPB41L4B LEMD3 VPS13C RNF213 CNKSR2 CLASP2 ANKRD50 RYR2 ARFGEF3 THADA VPS13A DLG1 ANKRD28 CTNND1 CLEC16A SNRNP200	1.58e-06	777	191	17	35844135
Pubmed	Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.	RYR1 RYR2 RYR3	1.62e-06	5	191	3	23918386
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR1 RYR2 RYR3	1.62e-06	5	191	3	19011160
Pubmed	Common deletion variants causing protocadherin-α deficiency contribute to the complex genetics of BAV and left-sided congenital heart disease.	PCDHA9 PCDHA10 PCDHA7	1.62e-06	5	191	3	34888534
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	UACA ZNF618 MCC FARSB CNKSR2 CLASP2 MDN1 SEPTIN3 PTPRD PPP6C SBF1 PTPRS N4BP2 CNKSR3 DLG1 ANKRD28 HERC2 CTNND1 GOLGA2	1.72e-06	963	191	19	28671696
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PCDHA9 ZFYVE16 MDN1 ANKRD28 HERC2 CTNND1 CLEC16A	1.83e-06	104	191	7	9205841
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	RYR1 RYR2 RYR3 ITPR2 SLC8A1	2.05e-06	38	191	5	30786075
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	2.09e-06	68	191	6	11230163
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	DNHD1 MYO1D COPA LAMA1 RNF213 RYR1 VPS13A LRP2 PLS3	2.48e-06	208	191	9	33230847
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CDH26 UACA RASA3 EPB41L4B PPFIBP2 VPS13C CARMIL1 FRMPD2 RNF213 WDR27 CLASP2 COG3 DNAH14 ARFGEF3 EXD3 THADA PPP4C PTPRS TBC1D14 DLG1 CTNND1 CLEC16A EIF3M VPS13B	2.48e-06	1489	191	24	28611215
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	SMG1 CLTCL1 IPO8 POLM CARMIL1 GDAP1 RNF213 RYR1 ARFGEF3 EIF2B3 VPS13A FBXO7 HERC2 EIF3M	2.55e-06	552	191	14	10737800
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	2.93e-06	72	191	6	10380929
Pubmed	Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle.	RYR1 RYR2 RYR3	3.22e-06	6	191	3	19549818
Pubmed	Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos.	RYR1 RYR2 RYR3	3.22e-06	6	191	3	26025922
Pubmed	A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.	CYP2A6 CYP2A7 CYP2A13	3.22e-06	6	191	3	7668294
Pubmed	FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells.	RYR1 RYR2 RYR3	3.22e-06	6	191	3	14592808
Pubmed	HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.	RYR1 RYR2 RYR3	3.22e-06	6	191	3	19009018
Pubmed	Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19.	CYP2A6 CYP2A7 CYP2A13	3.22e-06	6	191	3	8587134
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	3.44e-06	74	191	6	10817752
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UACA ZNF618 ANKRD62 RNF213 CUL7 ANKRD6 NPHP4 PPP4R3A FAN1 THADA N4BP2 UBR3 SNRNP200	3.86e-06	493	191	13	15368895
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	CLTCL1 IPO8 IPO7 UACA RASA3 MCC PPP4R3A PPP4C PPP6C GEMIN4 ANKRD28 SNRNP200 SNTB2 PPP1R12C	3.91e-06	573	191	14	28330616
Pubmed	UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer.	RNF213 ATIC HERC2 GOLGA2	4.90e-06	21	191	4	37422473
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	5.44e-06	80	191	6	10716726
Pubmed	Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.	CYP2A6 CYP2A7 CYP2A13	5.61e-06	7	191	3	9630227
Pubmed	Individual protomers of a G protein-coupled receptor dimer integrate distinct functional modules.	DLG1 SNTA1 SNTB2	5.61e-06	7	191	3	26617989
Pubmed	Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.	RYR1 RYR2 RYR3	5.61e-06	7	191	3	20962236
Pubmed	Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster.	CYP2A6 CYP2A7 CYP2A13	5.61e-06	7	191	3	14630516
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HDAC6 IPO7 COPA RASA3 MYO19 FARSB VTA1 RFC4 NCAPG FBXO22 MDN1 PPP6C SBF1 EIF2B3 GEMIN4 ANKRD28 UTP20 ATIC HERC2 CTNND1 SNRNP200 EIF3M	5.87e-06	1353	191	22	29467282
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CASP8AP2 ATP7A IPO8 IPO7 UACA LEMD3 CLASP2 ITPR2 THADA NCAPG MDN1 PPP6C SBF1 N4BP2 VPS13A DLG1 ANKRD28 HERC2 CTNND1 SNRNP200 PLS3 VPS13B SNTB2	8.00e-06	1487	191	23	33957083
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	COPA UACA RFC4 NCAPG FBXO22 PPP6C HERC2 SNTB2	8.08e-06	182	191	8	31067453
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	IPO8 IPO7 RNF213 ARFGEF3 THADA PPP6C EIF2B3 GEMIN4	8.41e-06	183	191	8	23956138
Pubmed	The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase.	IPO8 COPA STK17B CUL7 H3-4 SYT10 TMPRSS11B PPP6C CTNND1 MARCHF11 GOLGA2 SNTB2	8.75e-06	453	191	12	27113764
Interaction	COMTD1 interactions	COG2 IPO8 IPO7 STK17B APEX1 COG3 PPP4R3A THADA PPP6C EIF2B3 GEMIN4 ANKRD28 MAD2L2	5.85e-08	200	190	13	int:COMTD1
Interaction	NPTN interactions	SMG1 COG2 CLTCL1 IPO8 RNF213 ACAD10 XRCC3 COG3 ARFGEF3 CFD THADA MDN1 GEMIN4 UTP20 MAD2L2	6.51e-08	278	190	15	int:NPTN
Interaction	GPR17 interactions	COG2 IPO8 STK17B RNF213 COG3 ITPR2 ARFGEF3 GLMN THADA NCAPG MDN1 EIF2B3 GEMIN4 UBR3 UTP20	8.22e-08	283	190	15	int:GPR17
Interaction	CYP2A7 interactions	CYP2A6 CYP2A7 CYP2A13	8.25e-07	3	190	3	int:CYP2A7
Interaction	SCN2B interactions	COG2 RNF213 COG3 THADA MDN1 PTPRD EIF2B3 UTP20	3.25e-06	95	190	8	int:SCN2B
Interaction	TACSTD2 interactions	STK17B RNF213 COG3 ARFGEF3 THADA MDN1 EIF2B3 GEMIN4 MAD2L2	3.77e-06	129	190	9	int:TACSTD2
Interaction	OCIAD1 interactions	COG2 CLTCL1 MYO19 CARMIL1 APEX1 RNF213 COG3 PPP4R3A TRAK1 THADA NCAPG INSC VPS13A UTP20 MAD2L2	1.10e-05	419	190	15	int:OCIAD1
Interaction	VSIG2 interactions	COG2 IPO7 LEMD3 COG3 THADA	1.16e-05	32	190	5	int:VSIG2
Interaction	PCDHA9 interactions	PCDHA9 PCDHGB2 PCDHAC2 PCDHA10 PCDHA7	1.16e-05	32	190	5	int:PCDHA9
Interaction	C3orf18 interactions	SMG1 COG2 THADA NCAPG MDN1 EIF2B3 GEMIN4 UTP20	1.35e-05	115	190	8	int:C3orf18
Interaction	CD40 interactions	COG2 HDAC6 IPO8 RNF213 COG3 ARFGEF3 THADA GEMIN4 IKBKB	1.51e-05	153	190	9	int:CD40
Interaction	SLITRK1 interactions	FBXO22 PTPRD PTPRS	1.62e-05	6	190	3	int:SLITRK1
Interaction	ANKRD20A4P interactions	ANKRD20A2P ANKRD20A4P ANKRD20A1	1.62e-05	6	190	3	int:ANKRD20A4P
Interaction	ANKRD20A2P interactions	ANKRD20A2P ANKRD20A4P ANKRD20A1	2.81e-05	7	190	3	int:ANKRD20A2P
Interaction	GPR45 interactions	COG2 IPO8 HDHD5 MYO19 RNF213 ACAD10 XRCC3 COG3 THADA MDN1 GEMIN4 ANKRD28	2.92e-05	300	190	12	int:GPR45
Interaction	RAB35 interactions	ATP7A HDAC6 MYO1D UACA EPB41L4B LEMD3 VPS13C CARMIL1 ARFGEF3 CFD SBF1 PTPRS VPS13A LRP2 DLG1 CTNND1 CD200	3.20e-05	573	190	17	int:RAB35
Interaction	FZD10 interactions	IPO7 GLMN THADA NCAPG EIF2B3 GEMIN4	3.69e-05	66	190	6	int:FZD10
Interaction	MLNR interactions	IPO8 IPO7 STK17B MYO19 ACAD10 THADA	4.37e-05	68	190	6	int:MLNR
Interaction	FGF14 interactions	VPS13C EIF2B3 VPS13A GEMIN4 ANKRD28	4.53e-05	42	190	5	int:FGF14
Interaction	PCDHA10 interactions	PCDHA9 PCDHA13 PCDHA10 PCDHA7	4.90e-05	22	190	4	int:PCDHA10
Interaction	P2RY10 interactions	CLTCL1 ACAD10 COG3 ARFGEF3 GLMN THADA GEMIN4	6.58e-05	106	190	7	int:P2RY10
Interaction	FPR1 interactions	COG2 IPO8 STK17B RNF213 COG3 ARFGEF3 THADA GEMIN4	7.86e-05	147	190	8	int:FPR1
Interaction	RHOQ interactions	MYO1D ZFYVE16 LEMD3 VPS13C CARMIL1 CUL7 ARFGEF3 SBF1 PTPRS VPS13A LRP2 DLG1 CTNND1 SNTB2	8.17e-05	442	190	14	int:RHOQ
Interaction	CCDC187 interactions	MCC ASB15 FBXO22 INSC ANKRD28 GOLGA2	8.20e-05	76	190	6	int:CCDC187
Interaction	SIGLECL1 interactions	IPO8 IPO7 RNF213 ARFGEF3 THADA EIF2B3 GEMIN4	9.86e-05	113	190	7	int:SIGLECL1
Interaction	CALM3 interactions	HDAC6 MYO1D VPS13C APEX1 CUL7 PPEF2 ITPR2 CFD VPS13A DLG1 LTK EIF3M	1.06e-04	343	190	12	int:CALM3
Interaction	RHOJ interactions	MYO1D ZFYVE16 RASA3 LEMD3 VPS13C CARMIL1 CUL7 NPHP4 ARFGEF3 MDN1 SBF1 PTPRS VPS13A DLG1 UTP20 GOLGA2 SNTB2	1.09e-04	633	190	17	int:RHOJ
Interaction	WHRN interactions	MCC ANKRD28 MYO15A GOLGA2	1.13e-04	27	190	4	int:WHRN
Interaction	BTNL9 interactions	IPO8 IPO7 THADA NCAPG SBF1 EIF2B3 GEMIN4 MAD2L2	1.19e-04	156	190	8	int:BTNL9
Interaction	ANKRD20A1 interactions	ANKRD20A2P ANKRD20A4P ANKRD20A1	1.29e-04	11	190	3	int:ANKRD20A1
Interaction	TNFSF13B interactions	IPO8 IPO7 ARFGEF3 NCAPG MDN1 EIF2B3 GEMIN4	1.36e-04	119	190	7	int:TNFSF13B
Interaction	MYO5A interactions	HDAC6 MYO19 APEX1 DTNBP1 NPHP4 TRAK1 LRRIQ1 PLS3 FHIP2B	1.42e-04	204	190	9	int:MYO5A
Interaction	EFNB1 interactions	IPO8 IPO7 RNF213 ACAD10 TMPRSS11B THADA NCAPG SBF1 EIF2B3 MAD2L2	1.60e-04	255	190	10	int:EFNB1
Interaction	TNPO1 interactions	TCEA2 IPO8 IPO7 CUL7 XRCC3 H3-4 TMPRSS11B NCAPG CLEC16A SNRNP200 TMEM255A	1.62e-04	306	190	11	int:TNPO1
Interaction	RHPN1 interactions	CNKSR1 PPP4R3A MINDY3 GOLGA2 SNTB2	1.68e-04	55	190	5	int:RHPN1
Interaction	UNC93B1 interactions	COG2 IPO8 COPA RNF213 COG3 ITPR2 GLMN CFD THADA MDN1 PPP6C EIF2B3 GEMIN4	1.72e-04	417	190	13	int:UNC93B1
Interaction	WDTC1 interactions	IPO8 COPA STK17B VPS13C CUL7 H3-4 SYT10 GLMN SEPTIN3 PPP6C MAD2L2 CTNND1 MARCHF11 GOLGA2 SNTB2	1.75e-04	535	190	15	int:WDTC1
Interaction	PPFIA1 interactions	CNKSR1 PPFIBP2 APEX1 FBXO22 PPP4C PTPRD PTPRS LTK HERC2	2.03e-04	214	190	9	int:PPFIA1
Interaction	CD274 interactions	COG2 IPO8 IPO7 COPA FARSB APEX1 CLASP2 COG3 THADA UTP20 SNRNP200 PLS3	2.08e-04	369	190	12	int:CD274
Interaction	RYR2 interactions	RYR1 RYR2 RYR3 SNTA1 GOLGA2	2.16e-04	58	190	5	int:RYR2
Interaction	KCNA3 interactions	DNHD1 ATP7A HDAC6 IPO7 MYO1D COPA ZFYVE16 CARMIL1 LAMA1 FARSB RNF213 ANKRD50 RYR1 VPS13A GEMIN4 LRP2 DLG1 CTNND1 SNRNP200 PLS3	2.22e-04	871	190	20	int:KCNA3
Interaction	RHOF interactions	ATP7A HDAC6 IPO7 MYO1D UACA RASA3 LEMD3 ANKRD50 NCAPG MDN1 SBF1 VPS13A DLG1 UTP20 MAD2L2 VPS13B SNTB2	2.25e-04	673	190	17	int:RHOF
Cytoband	5q31	PCDHA9 PCDHGB2 CDKL3 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	5.79e-07	115	191	7	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHA9 PCDHGB2 CDKL3 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	2.70e-04	298	191	7	chr5q31
GeneFamily	Ankyrin repeat domain containing	ANKK1 UACA ANKRD62 ANKRD20A2P ANKRD20A3P ANKRD50 ASB15 ANKRD6 ANKRD20A4P ANKEF1 ANKRD30A ANKRD28 POTEJ AGAP6 ANKRD20A1 PPP1R12C PPP1R27	3.21e-12	242	135	17	403
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2 RYR3	4.07e-07	3	135	3	287
GeneFamily	Clustered protocadherins	PCDHA9 PCDHGB2 PCDHAC2 PCDHA13 PCDHA10 PCDHA7	8.15e-06	64	135	6	20
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	HDAC6 MYO1D ZFYVE16 RYR1 ARFGEF3 CSRNP3 ANKRD28 PPP1R12C PPP1R27	8.77e-06	181	135	9	694
GeneFamily	PDZ domain containing	CNKSR1 GIPC2 FRMPD2 CNKSR2 CNKSR3 DLG1 SNTA1 SNTB2	1.87e-05	152	135	8	1220
GeneFamily	Protein phosphatase catalytic subunits\|EF-hand domain containing	PPEF2 PPP4C PPP6C	1.10e-04	13	135	3	693
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SIGLEC12 BOC HSPG2 HMCN2 PTPRD PTPRS	1.33e-03	161	135	6	593
GeneFamily	Components of oligomeric golgi complex	COG2 COG3	1.50e-03	8	135	2	493
GeneFamily	Myosins, class I	MYO1G MYO1D	1.50e-03	8	135	2	1097
GeneFamily	Biogenesis of lysosomal organelles complex 1 \|BLOC-1 related complex	BLOC1S1 DTNBP1	1.50e-03	8	135	2	452
GeneFamily	Cytochrome P450 family 2	CYP2A6 CYP2A7 CYP2A13	2.24e-03	35	135	3	1001
GeneFamily	Sterile alpha motif domain containing	CNKSR1 PPFIBP2 CNKSR2 CNKSR3	4.27e-03	88	135	4	760
GeneFamily	EF-hand domain containing	MCC PPEF2 RYR2 RYR3 ANKEF1 PLS3	6.07e-03	219	135	6	863
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	EPB41L4B FRMPD2 MYO15A	6.18e-03	50	135	3	1293
GeneFamily	Cadherin related	CLSTN3 CLSTN2	6.99e-03	17	135	2	24
GeneFamily	Armadillo repeat containing\|Importins	IPO8 IPO7	7.83e-03	18	135	2	596
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 CNKSR2 RYR2 RYR3 ARFGEF3 COL24A1 SLC8A1 PTPRD LRP2 MYO15A	7.57e-09	184	191	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 CNKSR2 RYR2 RYR3 ARFGEF3 COL24A1 SLC8A1 PTPRD LRP2 MYO15A	7.57e-09	184	191	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 CNKSR2 RYR2 RYR3 ARFGEF3 COL24A1 SLC8A1 PTPRD LRP2 MYO15A	7.57e-09	184	191	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO1D CNKSR2 CLSTN2 RYR2 COL24A1 LRRIQ1 PTPRD VPS13A DLG1	1.17e-07	186	191	9	84ba666237c18189d7e7556bd92dd953af733c00
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CARMIL1 CNKSR2 CLSTN2 RYR2 SLC8A1 PTPRD CSRNP3 VPS13A DLG1	1.75e-07	195	191	9	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	facs-Marrow-T-cells-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G ATP7A PPFIBP2 VPS13C PPEF2 FZD7 SLC8A1 IKBKB	7.42e-07	170	191	8	a78d9789c3e7c84a36e1bd380192d7aba4a4d443
ToppCell	facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G ATP7A PPFIBP2 VPS13C PPEF2 FZD7 SLC8A1 IKBKB	7.42e-07	170	191	8	ff68600b945b3a5437b14e5411b3db800d0ccbe5
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CARMIL1 CNKSR2 CLSTN2 RYR2 SLC8A1 PTPRD VPS13A DLG1	1.71e-06	190	191	8	d594da827e3c16644952b9589cc12b947ce36279
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CARMIL1 CNKSR2 CLSTN2 RYR2 COL24A1 SLC8A1 PTPRD VPS13A	1.85e-06	192	191	8	5c7e8b80b44d9ce55c797cdf8267ac5382e26cac
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CDH26 RGS11 ANKRD20A3P SYT10 FAM135B CDK5R1 INSC	6.00e-06	160	191	7	14dfa519e68bab4bce890ddb66fa7763f18d9f19
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CDH26 RGS11 ANKRD20A3P SYT10 FAM135B CDK5R1 INSC	6.00e-06	160	191	7	839bbdfd4e4c7b48260c8bfb7670378634405e1d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CDH26 RGS11 ANKRD20A3P SYT10 FAM135B CDK5R1 INSC	6.00e-06	160	191	7	5b7789d4668ed7732babedc32d812233b430e0bd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CDH26 RGS11 ANKRD20A3P SYT10 FAM135B CDK5R1 INSC	6.00e-06	160	191	7	bba1486faaad5299e10f4fe17c6d149c28dc2560
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8\|TCGA-Liver / Sample_Type by Project: Shred V9	CYP2A6 XDH COG3 ASB15 F13B HMCN2 EDEM1	9.27e-06	171	191	7	c4a919fe3d56ae6df2fcab6686abacc10befc053
ToppCell	(0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts\|(0)_Normal/No_Treatment / Stress and Cell class	BOC MYO1D ST3GAL5 PTPRS PLS3 SNTA1 CD200	1.00e-05	173	191	7	c2a0f674681836b5a868c13f67caa7d555ef6519
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BOC CYP2A6 CYP2A7 CYP2A13 PCDHAC2 TRAK1 MUC5AC	1.04e-05	174	191	7	42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 SYT10 ITPR2 COL24A1 TBC1D14 ANKRD30A TMEM255A	1.08e-05	175	191	7	1d8da48236549c01381f777ce5b2937f9f86acc2
ToppCell	wk_15-18-Epithelial-PNS-intermediate_Schwann\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CLSTN2 ANKRD20A4P INSC ANKRD28 TMEM255A ANKRD20A1 FDXACB1	1.44e-05	183	191	7	d874aa9a856f79626c8a8371f6196a77b7d662ee
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BOC CYP2A6 CYP2A7 ANKRD6 LRP2 MUC5AC FHIP2B	1.66e-05	187	191	7	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	MYO1D CLASP2 RYR2 RYR3 SLC8A1 HMCN2 PLS3	1.71e-05	188	191	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EPB41L4B CARMIL1 CNKSR2 RYR2 PTPRD VPS13A DLG1	1.77e-05	189	191	7	a75226616340045b581d08429d2e123e041dee55
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CARMIL1 CNKSR2 CLSTN2 RYR2 SLC8A1 PTPRD VPS13A	1.83e-05	190	191	7	49e09cdb843b3d889a06a811aa5affae68b25a75
ToppCell	COPD-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	MYO1D ANKRD20A2P ANKRD20A3P ANKRD20A4P ST3GAL5 EDEM1 ANKRD20A1	1.90e-05	191	191	7	3480e6d27dd4291765bbbb2acdb6a2e4f02c8085
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ZFYVE16 LEMD3 ANKRD50 ARFGEF3 N4BP2 DLG1 VPS13B	2.03e-05	193	191	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYO1D ZFYVE16 CHADL ARFGEF3 PTPRD LRP2 DLG1	2.10e-05	194	191	7	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EPB41L4B LAMA1 DNAH14 RYR3 HMCN2 PTPRD MYO15A	2.17e-05	195	191	7	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EPB41L4B LAMA1 DNAH14 RYR3 HMCN2 PTPRD MYO15A	2.17e-05	195	191	7	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	AT2_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	HSPG2 PCDHGB2 ANKRD20A2P ANKRD20A3P RYR3 ANKRD20A4P	2.18e-05	131	191	6	ff4e618bd944f852bbd34438f740187aca82460f
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MYO1D CLASP2 MED13L ITPR2 UBR3 DLG1 VPS13B	2.47e-05	199	191	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	PCDHA9 ANKRD62 PCDHA10 RGS11 CNKSR2 RYR2 INSC	2.55e-05	200	191	7	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	UACA GBP7 RNF213 PIK3C2B CTNND1 SNTB2 CD200	2.55e-05	200	191	7	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PCDHA9 ANKRD62 PCDHA10 RGS11 CNKSR2 RYR2 INSC	2.55e-05	200	191	7	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PCDHA9 ANKRD62 PCDHA10 RGS11 CNKSR2 RYR2 INSC	2.55e-05	200	191	7	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	Neuronal-Excitatory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	MYO1D CARMIL1 CNKSR2 CLSTN2 RYR2 PTPRD DLG1	2.55e-05	200	191	7	4409065bc7aa995354c71e0f9d6f3726cf393d6b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 SYT10 ITPR2 COL24A1 TBC1D14 ANKRD30A	6.01e-05	157	191	6	c17c5c01fcb65c453690c265ec4f300ecdfefd34
ToppCell	severe_COVID-19-pDC\|severe_COVID-19 / disease group, cell group and cell class (v2)	HSPG2 RYR1 PTPRS CNKSR3 LTK SNTA1	6.44e-05	159	191	6	ea5088d27e42b8850455764d53b757ea8d8f14bc
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKK1 LAMA1 RYR2 RYR3 COL24A1 LRP2	6.67e-05	160	191	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 SYT10 ITPR2 COL24A1 TBC1D14 ANKRD30A	6.67e-05	160	191	6	174a4ab27114efcc63be36929b80680be3c35c9b
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKK1 LAMA1 RYR2 RYR3 COL24A1 LRP2	6.67e-05	160	191	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	COVID-19_Severe-multiplets\|World / disease group, cell group and cell class	RGS11 NCAPG SEPTIN3 HMCN2 ANKRD20A1 PPP1R27	7.39e-05	163	191	6	6db4271c2d47a9c333964f36d2c32207115e52cd
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1\|E16.5-samps / Age Group, Lineage, Cell class and subclass	VPS13C XDH PCDHA7 MED13L RYR3 SNTA1	7.39e-05	163	191	6	f1ec2625b52664308968b01d8e0275e1e0751480
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3_(Neuron.Gad1Gad2.Cplx3)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	TRPC5OS PLA2G4D F13B PDE11A	7.83e-05	53	191	4	9c6aba539d540211b2309da1af6a531f3275a49d
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3_(Neuron.Gad1Gad2.Cplx3)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	TRPC5OS PLA2G4D F13B PDE11A	7.83e-05	53	191	4	846e031024ad3a4f5c6640b61cf4a0e69dbbcd1c
ToppCell	droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIBP2 PPEF2 RYR1 THADA SEPTIN3 ST3GAL5	8.45e-05	167	191	6	f33cef917fa733adf6d5a9a9e989a4d9fd462a8f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 MCC SYT10 ITPR2 TBC1D14 ANKRD30A	9.02e-05	169	191	6	2a21f2cef959526bfe3c8f081f4f7e9dd4e01a37
ToppCell	severe-HSPC\|World / disease stage, cell group and cell class	ZNF805 CHADL ANKRD50 DNAH14 COL24A1 FAM124B	9.02e-05	169	191	6	b0421b73bfdc92f7a2762b4b670b9eae124aa702
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 SYT10 ITPR2 COL24A1 TBC1D14 ANKRD30A	9.02e-05	169	191	6	4b3a7b4a497178799b6b2f0b744f5fb752cee31a
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 UACA XRCC3 NCAPG PTPRS PLS3	9.02e-05	169	191	6	2833a8a7094e4d407eb923f2bc59b9b112c6bae4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 SYT10 ITPR2 COL24A1 TBC1D14 ANKRD30A	9.02e-05	169	191	6	a4fd646b9bf87225131fca530bd6b52df9eaf489
ToppCell	facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAD10 CHADL ANKRD6 AGXT SNTA1 FDXACB1	9.32e-05	170	191	6	d70aaa0f4e5034bb9f61b832b5f9123870936d3c
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HSPG2 FAN1 CDK5R1 THADA CNKSR3 CD200	9.32e-05	170	191	6	55fe16d98ea284d05fb899888e4569c685644c7b
ToppCell	normal-na-Lymphocytic_B-B_plasma-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	HSPG2 CNKSR1 MYO1D FAN1 ANKEF1 LTK	9.32e-05	170	191	6	c5b87974dfddf9780051f7f5693eeeb0c606a3fe
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 MCC SYT10 ITPR2 TBC1D14 ANKRD30A	1.03e-04	173	191	6	0bc2aacae60c6d3276b0949eb0748b4ac1f56e54
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HSPG2 GIPC2 UACA ITPR2 PIK3C2B CD200	1.06e-04	174	191	6	18ab52d8bbca0507fee220e0c4fc765fc47dda34
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MCC RYR3 COL24A1 ANKRD20A4P ANKRD20A5P ANKRD20A1	1.06e-04	174	191	6	99eb5e1aee136c7039e23b68a43a0fa3d775859f
ToppCell	TCGA-Colorectal-Recurrent_Tumor\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CYP2A6 CYP2A7 GBP7 CFHR5 F13B AGXT	1.09e-04	175	191	6	7f74961436f88c0e380819095e6104489914d765
ToppCell	TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CYP2A6 CYP2A7 GBP7 CFHR5 F13B AGXT	1.09e-04	175	191	6	bee8f31f036dfcf9fc6ed29156554771a9ee3c60
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 SYT10 ITPR2 COL24A1 TBC1D14 ANKRD30A	1.13e-04	176	191	6	c2c4306476989bc2fb30dab00250ef7915842f13
ToppCell	PBMC-Mild-cDC_11\|Mild / Compartment, Disease Groups and Clusters	CARMIL1 RGS11 CLSTN2 SEPTIN3 SNTA1 CD200	1.16e-04	177	191	6	974305e4c0eff90134c4e58cf11b955d1eee0501
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RNF144B BOC MYO1D CLSTN2 SYT10 CD200	1.16e-04	177	191	6	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	3'-Adult-Appendix-Epithelial-epithelial_progenitor_cell-Stem_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO1G GDAP1 UTP20 FAM124B FDXACB1 PPP1R27	1.16e-04	177	191	6	34458f1eb7f3b1fd0cb9904529c01a9ca2f15500
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 UACA POLM CUL7 ANKRD28 TMEM255A	1.24e-04	179	191	6	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|368C / Donor, Lineage, Cell class and subclass (all cells)	RNF144B ACHE FARSB ANKRD6 NCAPG TRMT1L	1.24e-04	179	191	6	ec69e1dd897414033ba5b007aa82655a79adca6c
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MCC ANKRD62 CLSTN2 RYR3 COL24A1 ANKRD20A1	1.24e-04	179	191	6	f65889bf1e41396979cce44a5e63f49dea2bbd9b
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCDHA9 ANKRD62 RGS11 ADARB2 PTPRD INSC	1.24e-04	179	191	6	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPB41L4B WDR27 CUL7 CFD SBF1 GEMIN4	1.27e-04	180	191	6	7368ab31c3273374ef260f0d710d4eea83cbc4a2
ToppCell	facs-Marrow-T-cells-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F13B ARFGEF3 PPP6C INSC MAD2L2 EDEM1	1.31e-04	181	191	6	57f0cc749ae8b6a3d77e2af31f9a6e4739c57049
ToppCell	droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UACA MCC ITPR2 PIK3C2B FAM124B CD200	1.31e-04	181	191	6	92d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA1 RIPOR3 CLSTN2 ADARB2 SYT10 CD200	1.31e-04	181	191	6	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PPFIBP2 SYT10 ITPR2 COL24A1 TBC1D14 ANKRD30A	1.31e-04	181	191	6	30729f0364f719c044712a51453e22dc2c1a232b
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MCC FARSB CNKSR2 THADA FAM124B CD200	1.31e-04	181	191	6	9275531e896e118cee043ed94fd31a0070d9581c
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGS11 CNKSR2 CLASP2 ARFGEF3 SEPTIN3 PTPRS	1.31e-04	181	191	6	7f99002a6411117cc2361334c7c9228e20c574b4
ToppCell	facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F13B ARFGEF3 PPP6C INSC MAD2L2 EDEM1	1.31e-04	181	191	6	d01b35cc2fc57991a35be6a06cb7351fbabd9a11
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA1 RIPOR3 CLSTN2 ADARB2 SYT10 CD200	1.35e-04	182	191	6	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RNF144B GBP7 RNF213 ITPR2 SLC8A1 ST3GAL5	1.35e-04	182	191	6	e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MCC ANKRD62 CLSTN2 RYR3 COL24A1 ANKRD20A1	1.39e-04	183	191	6	65f2a5895d166189a095cf7ea9dda171f0419b08
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IPO7 GBP7 MCC PIK3C2B CNKSR3 CD200	1.44e-04	184	191	6	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	COPD-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P ANKRD20A4P ST3GAL5 EDEM1 ANKRD20A1	1.44e-04	184	191	6	42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94
ToppCell	wk_08-11-Epithelial-PNS-PCP4+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CYP2A6 RGS11 CNKSR2 CLSTN2 SEPTIN3 MARCHF11	1.44e-04	184	191	6	eac2a9089913f33a961ba11519b53645790f2056
ToppCell	droplet-Lung-LUNG-1m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR1 CDKL3 ARFGEF3 LRP2 ANKRD28 HMGXB3	1.52e-04	186	191	6	e52cf44989c57c433bf82e9fa13b4643e88f3577
ToppCell	droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR1 CDKL3 ARFGEF3 LRP2 ANKRD28 HMGXB3	1.52e-04	186	191	6	4c0b59d845b79323e7a3287e7c4d249f5f322556
ToppCell	IPF-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P ANKRD20A4P ST3GAL5 EDEM1 ANKRD20A1	1.52e-04	186	191	6	962c2dada19185628ead77c32fcb07fa95114247
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCDHA9 UACA ANKRD62 PCDHA10 RGS11 RYR2	1.52e-04	186	191	6	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	COPA ZFYVE16 STK17B ITPR2 SLC8A1 DLG1	1.57e-04	187	191	6	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BOC HSPG2 PCDHA9 FZD7 COL24A1 PTPRD	1.61e-04	188	191	6	b382d18fb09fb2869f3c151efa71540a7f5ed229
ToppCell	IPF-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	MYO1D ANKRD20A2P ANKRD20A3P ANKRD20A4P ST3GAL5 ANKRD20A1	1.61e-04	188	191	6	47bb6caf84f70a1cda7d09803afdfd5182772e66
ToppCell	IPF-Myeloid-cDC1\|IPF / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P ANKRD20A4P ST3GAL5 EDEM1 ANKRD20A1	1.61e-04	188	191	6	2331a2bae1383820d598e93aa86c75b101069bac
ToppCell	(1)_Osterolineage_cells-(10)_OLC-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	STK17B PPFIBP2 PTPRD PTPRS INSC CD200	1.66e-04	189	191	6	46c5b975fb9d33017f2d9b7770d45a8bdf95baa2
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BOC PPFIBP2 SYT10 RYR2 COL24A1 PTPRS	1.66e-04	189	191	6	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RNF144B HSPG2 GIPC2 MCC RGS11 PIK3C2B	1.71e-04	190	191	6	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	facs-Thymus-Epithelium-24m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF144B BOC GDAP1 PCDHAC2 CFD HR	1.76e-04	191	191	6	eec14997d2bfc7e6b5a601afc43a147f6b96d668
ToppCell	facs-Thymus-Epithelium-24m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF144B BOC GDAP1 PCDHAC2 CFD HR	1.76e-04	191	191	6	1730ec5dc1cfd2f0cba7e21555641c7bce97e09d
ToppCell	hematopoetic_progenitors-CD34+_CLP\|World / Lineage and Cell class	APEX1 MED13L COL24A1 PTPRD ANKRD28 CD200	1.76e-04	191	191	6	32f2537c97c9984629d61c6f34a337f555146ad4
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 CDH26 XDH ARFGEF3 PTPRD	1.76e-04	191	191	6	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GBP7 MCC PIK3C2B CNKSR3 CTNND1 CD200	1.76e-04	191	191	6	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HSPG2 GIPC2 UACA PIK3C2B PLS3 CD200	1.76e-04	191	191	6	04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0
ToppCell	facs-Thymus-Epithelium-24m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF144B BOC GDAP1 PCDHAC2 CFD HR	1.76e-04	191	191	6	4b77abc68bd72c64e7062f9527fe9d9605289ceb
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HSPG2 GIPC2 UACA PIK3C2B PLS3 CD200	1.76e-04	191	191	6	db8dd6bbba803585bdd6a55d5c403d383f2e9acf
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	CARMIL1 RIPOR3 CLSTN2 CFD PTPRD PTPRS	1.76e-04	191	191	6	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	CARMIL1 RIPOR3 CLSTN2 CFD COL24A1 PTPRS	1.81e-04	192	191	6	356160b113c3305a61ceeaff33ce3c9da0be2878
Drug	cis-diammineplatinum(II	RYR1 RYR2 RYR3	5.63e-07	3	189	3	CID000159790
Drug	2-hydroxyheptanoic acid	RYR1 RYR2 RYR3	5.63e-07	3	189	3	CID002750949
Drug	8N3-cADPR	RYR1 RYR2 RYR3	5.63e-07	3	189	3	CID000127713
Drug	aminodantrolene	RYR1 RYR2 RYR3	5.63e-07	3	189	3	CID009570289
Drug	2-hydroxycarbazole	RYR1 RYR2 RYR3	5.63e-07	3	189	3	CID000093551
Drug	2'-methoxyacetophenone	CYP2A6 CYP2A7 CYP2A13	5.63e-07	3	189	3	CID000068481
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR2 RYR3	5.63e-07	3	189	3	CID005748312
Drug	4,4'-dithiodipyridine	CYP2A6 APEX1 XDH RYR1 RYR2 RYR3	1.88e-06	45	189	6	CID000075846
Drug	PCB74	RYR1 RYR2 RYR3	2.24e-06	4	189	3	CID000036218
Drug	148504-47-6	RYR1 RYR2 RYR3	2.24e-06	4	189	3	CID006444275
Drug	SC 38249	RYR1 RYR2 RYR3	2.24e-06	4	189	3	CID000134834
Drug	AC1L1U7A	RYR1 RYR2 RYR3	2.24e-06	4	189	3	CID000035682
Drug	Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A	PCDHA9 PPFIBP2 MCC CLSTN2 SBF1 AGXT SHCBP1L MUC5AC SNTA1 VPS13B	6.44e-06	198	189	10	2623_UP
Drug	Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CNKSR1 HDAC6 STK17B ANKRD6 TRAK1 CFD MINDY3 FBXO22 SBF1 HMGXB3	7.04e-06	200	189	10	4789_DN
Drug	Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	COPA RASA3 CLASP2 CLSTN2 ANKRD6 ITPR2 MINDY3 EXD3 SBF1 HMGXB3	7.04e-06	200	189	10	3276_DN
Drug	parathion	CYP2A6 CYP2A7 CYP2A13 ACHE CLSTN2 CFD VPS13A	1.09e-05	91	189	7	CID000000991
Drug	chloro-m-cresol	RYR1 RYR2 RYR3	1.11e-05	6	189	3	CID000012008
Drug	MBED	RYR1 RYR2 RYR3	1.11e-05	6	189	3	CID000129958
Drug	AC1O528X	RYR1 RYR2 RYR3	1.11e-05	6	189	3	CID006475857
Drug	NSC114784	RYR1 RYR2 RYR3	1.11e-05	6	189	3	CID000419425
Drug	methylcoumarin	BOC RYR1 RYR2 RYR3	1.29e-05	18	189	4	CID000007092
Drug	[[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate	RYR1 RYR2 RYR3	1.92e-05	7	189	3	CID009547999
Drug	Azumoleno	RYR1 RYR2 RYR3	1.92e-05	7	189	3	CID000056259
Drug	Br2BAPTA	RYR1 RYR2 RYR3	1.92e-05	7	189	3	CID003081001
Drug	TTNPB; Up 200; 0.1uM; MCF7; HG-U133A	TCEA2 CNKSR1 CLSTN3 CDKL3 ADARB2 TRAK1 GLMN MINDY3 IKBKB	3.12e-05	190	189	9	223_UP
Drug	(+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA	CUL7 NPHP4 PPP4R3A FAN1 VPS13A LRP2 HMGXB3 SNRNP200 EIF3M	3.68e-05	194	189	9	954_UP
Drug	sodium 4-phenylbutyrate; Down 200; 1000uM; PC3; HG-U133A	TCEA2 HSPG2 RASA3 LEMD3 CDKL3 GLMN PPP4C SBF1 AGXT	3.83e-05	195	189	9	434_DN
Drug	Molsidomine [25717-80-0]; Down 200; 16.6uM; HL60; HG-U133A	STK17B GMIP NPHP4 TRAK1 MINDY3 PIK3C2B GEMIN4 CLEC16A EIF3M	4.15e-05	197	189	9	1711_DN
Drug	Famotidine [76824-35-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CDKL3 MCC CLASP2 CLSTN2 XRCC3 SBF1 ST3GAL5 EIF3M GOLGA2	4.15e-05	197	189	9	1529_DN
Drug	Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A	IPO8 ZFYVE16 TRAK1 ITPR2 FZD7 EXD3 SBF1 VPS13A CLEC16A	4.49e-05	199	189	9	7233_DN
Drug	ts M	ACHE RYR1 RYR2 RYR3 CFD	4.79e-05	48	189	5	CID000428025
Drug	PCB 95	RYR1 RYR2 RYR3	6.47e-05	10	189	3	CID000038012
Drug	tert-butylmagnesium chloride	ACHE CFD	6.85e-05	2	189	2	CID000101830
Drug	propargyl ether	CYP2A6 CYP2A13	6.85e-05	2	189	2	ctd:C531209
Drug	Hempa	CYP2A6 CYP2A13	6.85e-05	2	189	2	ctd:D006492
Drug	5'-adenylyl (beta,gamma-methylene)diphosphonate	RYR1 RYR3	6.85e-05	2	189	2	ctd:C005147
Drug	ORF 17578	ACHE CFD	6.85e-05	2	189	2	CID003037245
Drug	nicotine imine	CYP2A6 CYP2A13	6.85e-05	2	189	2	ctd:C034629
Drug	alpha-nicotyrine	CYP2A6 CYP2A13	6.85e-05	2	189	2	ctd:C008615
Drug	N-nitrosoguvacoline	CYP2A6 CYP2A13	6.85e-05	2	189	2	ctd:C036676
Drug	AC1L9EL8	ACHE CFD	6.85e-05	2	189	2	CID000443397
Drug	PCB 66	RYR1 RYR2 RYR3	8.85e-05	11	189	3	CID000036185
Drug	Trimetazidine	ACHE RYR2 SLC8A1	8.85e-05	11	189	3	ctd:D014292
Drug	R 478	RYR1 RYR2 RYR3	8.85e-05	11	189	3	CID000084223
Drug	8-amino-cADPR	RYR1 RYR2 RYR3	8.85e-05	11	189	3	CID003081323
Drug	chloroacetyl chloride	BOC CYP2A6 CYP2A7 CYP2A13 CLSTN2	9.29e-05	55	189	5	CID000006577
Drug	Ryanodine	RYR1 RYR2 RYR3	1.17e-04	12	189	3	ctd:D012433
Drug	AC1NUTUV	CYP2A6 XDH CD200	1.17e-04	12	189	3	CID005460886
Disease	visceral adipose tissue measurement, body mass index	PCDHA9 PCDHAC2 PCDHA13 PCDHA10 PCDHA7 CNKSR2 CLSTN2 MAD2L2	7.22e-08	87	183	8	EFO_0004340, EFO_0004765
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2 RYR3	2.35e-07	3	183	3	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2 RYR3	2.35e-07	3	183	3	DOID:8545 (implicated_via_orthology)
Disease	Cohen syndrome (implicated_via_orthology)	VPS13C VPS13A VPS13B	2.35e-07	3	183	3	DOID:0111590 (implicated_via_orthology)
Disease	metal metabolism disorder (implicated_via_orthology)	ATP7A BLOC1S1 DTNBP1	9.34e-07	4	183	3	DOID:896 (implicated_via_orthology)
Disease	Colorectal Carcinoma	BOC CYP2A6 CLSTN3 FRMPD2 LAMA1 MCC CNKSR2 CLSTN2 ADARB2 NCAPG PTPRD CSRNP3 PTPRS VPS13A LRP2 SNRNP200 HR	2.00e-06	702	183	17	C0009402
Disease	1,5 anhydroglucitol measurement	PCDHA9 PCDHA13 PCDHA10 PCDHA7	3.01e-05	29	183	4	EFO_0008009
Disease	Parkinson's disease 23 (implicated_via_orthology)	VPS13C VPS13A	3.83e-05	2	183	2	DOID:0060896 (implicated_via_orthology)
Disease	choreaacanthocytosis (implicated_via_orthology)	VPS13C VPS13A	3.83e-05	2	183	2	DOID:0050766 (implicated_via_orthology)
Disease	cutaneous melanoma, hair color	GIPC2 RASA3 PPFIBP2 MED13L HERC2	4.22e-05	62	183	5	EFO_0000389, EFO_0003924
Disease	vital capacity	HSPG2 PCDHA9 IPO8 EPB41L4B PCDHA13 WDR27 PCDHA10 PCDHA7 VTA1 RYR2 SLC8A1 LRRIQ1 PTPRD PIK3C2B AGXT LRP2 DLG1 FBXL20 NLRP4 PDE11A	9.03e-05	1236	183	20	EFO_0004312
Disease	autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology)	VPS13C VPS13A	1.14e-04	3	183	2	DOID:0111611 (implicated_via_orthology)
Disease	complement C5 measurement	CFHR5 F13B	1.14e-04	3	183	2	EFO_0020278
Disease	platelet-derived growth factor receptor alpha measurement	CFHR5 F13B	1.14e-04	3	183	2	EFO_0021844
Disease	Malignant neoplasm of breast	BOC ACHE XDH CFHR5 XRCC3 COG3 RFC4 FCRL3 PTPRD N4BP2 ANKEF1 ANKRD30A UTP20 HERC2 IKBKB PLS3 EIF3M VPS13B	1.34e-04	1074	183	18	C0006142
Disease	Lung Diseases, Interstitial	COPA FARSB	2.28e-04	4	183	2	C0206062
Disease	angiotensinogen measurement	COG2 AGXT	2.28e-04	4	183	2	EFO_0008025
Disease	Hypoplastic Left Heart Syndrome	PCDHA9 PCDHA13	3.78e-04	5	183	2	C0152101
Disease	Intellectual Disability	CNKSR1 LAMA1 MCC FARSB MED13L H3-4 ST3GAL5 IER3IP1 LRP2 ATIC	5.09e-04	447	183	10	C3714756
Disease	neutrophil count, basophil count	MYO1G PCDHA9 PCDHA13 PCDHA10 PCDHA7 VTA1 THADA	5.20e-04	224	183	7	EFO_0004833, EFO_0005090
Disease	Strabismus	ZNF618 ADARB2 PTPRD	7.61e-04	29	183	3	HP_0000486
Disease	alpha-1-antichymotrypsin complex measurement	CFD SERPINA13P	7.87e-04	7	183	2	EFO_0008018
Disease	susceptibility to mononucleosis measurement	ANKRD50 RYR2 MDN1 PTPRD	9.04e-04	69	183	4	EFO_0008403
Disease	bitter non-alcoholic beverage consumption measurement	CYP2A6 N4BP2 FAM124B	1.02e-03	32	183	3	EFO_0010093
Disease	pursuit maintenance gain measurement	MYO1G IPO7 CARMIL1 CNKSR2 PTPRD	1.04e-03	123	183	5	EFO_0008433
Disease	cerebellar ataxia (implicated_via_orthology)	VPS13C VPS13A	1.05e-03	8	183	2	DOID:0050753 (implicated_via_orthology)
Disease	Abnormality of refraction	SMG1 PCDHA9 MYO1D FRMPD2 PCDHA13 PCDHA10 PCDHA7 CNKSR2 ITPR2 SLC8A1 FBXO7 PDE11A	1.07e-03	673	183	12	HP_0000539
Disease	Sarcomatoid Renal Cell Carcinoma	DNHD1 ACHE CUL7 ASB15 RYR1	1.24e-03	128	183	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	DNHD1 ACHE CUL7 ASB15 RYR1	1.24e-03	128	183	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	DNHD1 ACHE CUL7 ASB15 RYR1	1.24e-03	128	183	5	C1266044
Disease	Papillary Renal Cell Carcinoma	DNHD1 ACHE CUL7 ASB15 RYR1	1.24e-03	128	183	5	C1306837
Disease	Renal Cell Carcinoma	DNHD1 ACHE CUL7 ASB15 RYR1	1.24e-03	128	183	5	C0007134
Disease	Tremor, Neonatal	ATP7A ACHE	1.34e-03	9	183	2	C0235843
Disease	Tremor, Perioral	ATP7A ACHE	1.34e-03	9	183	2	C0235078
Disease	Nerve Tremors	ATP7A ACHE	1.34e-03	9	183	2	C0235083
Disease	Tremor, Limb	ATP7A ACHE	1.34e-03	9	183	2	C0235081
Disease	Tremor, Muscle	ATP7A ACHE	1.34e-03	9	183	2	C0235082
Disease	Senile Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0149840
Disease	Pill Rolling Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0751564
Disease	Tremor, Semirhythmic	ATP7A ACHE	1.34e-03	9	183	2	C0751565
Disease	Action Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0234376
Disease	Passive Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0234377
Disease	Static Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0234378
Disease	Resting Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0234379
Disease	Intermittent Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0234372
Disease	Fine Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0234373
Disease	Coarse Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0234374
Disease	Massive Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0234375
Disease	Persistent Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0234370
Disease	Continuous Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0234371
Disease	Darkness Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0234381
Disease	Involuntary Quiver	ATP7A ACHE	1.34e-03	9	183	2	C1527384
Disease	Saturnine Tremor	ATP7A ACHE	1.34e-03	9	183	2	C0040827
Disease	pulmonary hypertension (biomarker_via_orthology)	RYR1 RYR2 RYR3 CTNND1	1.57e-03	80	183	4	DOID:6432 (biomarker_via_orthology)
Disease	Profound Mental Retardation	CNKSR1 LAMA1 MCC MED13L H3-4	1.79e-03	139	183	5	C0020796
Disease	Mental Retardation, Psychosocial	CNKSR1 LAMA1 MCC MED13L H3-4	1.79e-03	139	183	5	C0025363
Disease	Mental deficiency	CNKSR1 LAMA1 MCC MED13L H3-4	1.79e-03	139	183	5	C0917816
Disease	forced expiratory volume, response to bronchodilator	CYP2A6 CYP2A7 GIPC2 GDAP1 CNKSR2 CLSTN2 COL24A1 SLC8A1 PTPRD	1.93e-03	445	183	9	EFO_0004314, GO_0097366
Disease	Tremor	ATP7A ACHE	2.03e-03	11	183	2	C0040822
Disease	bitter beverage consumption measurement	CYP2A6 N4BP2 FAM124B	2.26e-03	42	183	3	EFO_0010089
Disease	eosinophil count	TCEA2 UACA STK17B PRXL2B TRMT112 CDKL3 ACAD10 GMIP GLMN THADA PPP4C MDN1 PIK3C2B TBC1D14 BTN2A3P MUC5AC CLEC16A SNRNP200 CD200	2.34e-03	1488	183	19	EFO_0004842
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DNHD1 ACHE CUL7 ASB15 RYR1	2.35e-03	148	183	5	C0279702
Disease	nicotine metabolite ratio	CYP2A6 CYP2A7	2.42e-03	12	183	2	EFO_0007794
Disease	hippocampal volume	LEMD3 GDAP1 MED13L RYR2 RYR3 PTPRD PDE11A	2.63e-03	297	183	7	EFO_0005035
Disease	fatty acid measurement, fetal genotype effect measurement, breast milk measurement	COG3 FAM135B	2.85e-03	13	183	2	EFO_0005110, EFO_0007959, EFO_0009092
Disease	Charcot-Marie-Tooth disease type 4	GDAP1 SBF1	2.85e-03	13	183	2	cv:C4082197
Disease	pneumonia	GIPC2 EXD3 MUC5AC	3.11e-03	47	183	3	EFO_0003106
Disease	fatty acid measurement, breast milk measurement, parental genotype effect measurement	COG3 FAM135B	3.31e-03	14	183	2	EFO_0005110, EFO_0005939, EFO_0009092
Disease	Hermansky-Pudlak syndrome (implicated_via_orthology)	BLOC1S1 DTNBP1	3.31e-03	14	183	2	DOID:3753 (implicated_via_orthology)
Disease	Generalized seizures	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0234533
Disease	Clonic Seizures	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0234535
Disease	Convulsive Seizures	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0751494
Disease	Seizures, Sensory	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0751496
Disease	Non-epileptic convulsion	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0751056
Disease	Atonic Absence Seizures	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0751123
Disease	Complex partial seizures	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0149958
Disease	Single Seizure	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0751110
Disease	Nonepileptic Seizures	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C3495874
Disease	Visual seizure	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0270824
Disease	Epileptic drop attack	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0270846
Disease	Vertiginous seizure	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0422855
Disease	Gustatory seizure	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0422854
Disease	Seizures, Somatosensory	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0422850
Disease	Olfactory seizure	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0422853
Disease	Seizures, Auditory	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0422852
Disease	Generalized Absence Seizures	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C4505436
Disease	Jacksonian Seizure	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C0022333
Disease	Epileptic Seizures	ATP7A ACHE APEX1 SLC8A1	3.66e-03	101	183	4	C4317109
Disease	Absence Seizures	ATP7A ACHE APEX1 SLC8A1	3.79e-03	102	183	4	C4316903
Disease	Convulsions	ATP7A ACHE APEX1 SLC8A1	3.79e-03	102	183	4	C4048158
Disease	Tonic Seizures	ATP7A ACHE APEX1 SLC8A1	3.79e-03	102	183	4	C0270844
Disease	cerebral amyloid angiopathy	CYP2A6 MCC CNKSR2	3.93e-03	51	183	3	EFO_0006790
Disease	Seizures, Focal	ATP7A ACHE APEX1 SLC8A1	4.06e-03	104	183	4	C0751495
Disease	Myoclonic Seizures	ATP7A ACHE APEX1 SLC8A1	4.06e-03	104	183	4	C4317123
Disease	Tonic - clonic seizures	ATP7A ACHE APEX1 SLC8A1	4.06e-03	104	183	4	C0494475
Disease	partial epilepsy	FZD7 PTPRD	4.89e-03	17	183	2	EFO_0004263
Disease	Moyamoya Disease	ATP7A RNF213	4.89e-03	17	183	2	C0026654
Disease	polyp of colon	BOC ACAD10 PIK3C2B	5.11e-03	56	183	3	MONDO_0021400
Disease	urate measurement, bone density	CASP8AP2 ZNF618 CARMIL1 MCC RIPOR3 CLASP2 DTNBP1 DNAH14 ITPR2 PTPRD	5.48e-03	619	183	10	EFO_0003923, EFO_0004531
Disease	brain infarction	GIPC2 EIF2B3	5.48e-03	18	183	2	EFO_0004277

Protein segments in the cluster

Peptide	Gene	Start	Entry
QEEACAVILLEHGAN	ANKRD20A1	111	Q5TYW2
REALSDVVGDHNVVC	ACHE	426	P22303
CNEAILHLVVAGLDS	BTN2A3P	131	Q96KV6
VGSDHELQAVLLTCL	CDK5R1	216	Q15078
IVHNLDGCEISLVGD	CLSTN3	701	Q9BQT9
LCGHDAVREALVDQA	CYP2A6	81	P11509
CLTEALVDHLNVGVA	BLOC1S1	61	P78537
QEEACAVILLEHGAN	ANKRD20A4P	111	Q4UJ75
EQVRLLLAHEVDVDC	ANKK1	376	Q8NFD2
LLLDHGACVDAQERE	ANKK1	446	Q8NFD2
NGLLADIVHACLQID	CDKL3	256	Q8IVW4
LLAVNNVCLEEVTHE	DLG1	371	Q12959
QEEACAVILLEHGAN	ANKRD20A5P	111	A0PJZ0
NDVHCTEVLLAAGAD	ASB15	361	Q8WXK1
CVNGHEEVVTFLVDR	ANKRD30A	81	Q9BXX3
NGHETCVELLLEQEV	ANKRD28	766	O15084
QEEVCASILLEHGAN	ANKRD62	116	A6NC57
CKIHSVDLQAVGLED	ACAD10	396	Q6JQN1
CHAGQQDIVELLVES	ANKEF1	566	Q9NU02
ICVGDHIESINGENI	GIPC2	156	Q8TF65
FEGHRLICEALIEQG	ANKRD50	856	Q9ULJ7
ATALCIAAQEGHIDV	ANKRD50	1046	Q9ULJ7
CLGIVGAQVALEEAV	DNHD1	196	Q96M86
VLCGDLNVAHEEIDL	APEX1	206	P27695
LHNLDFCDILVIGGD	CLSTN2	691	Q9H4D0
IEVTVLHIDQLGCSG	CASP8AP2	1701	Q9UKL3
IAALIHEGCALDRQD	ANKRD6	91	Q9Y2G4
ILLLAHGSCEEVNET	AGAP6	581	Q5VW22
VAVDDELCGLIAIAD	ATP7A	1216	Q04656
RVVQELLEHGVCEEV	POLM	211	Q9NP87
AGHCTLLVEVVDVND	PCDHA9	331	Q9Y5H5
SHVAEGETLDLNCVV	HSPG2	2736	P98160
AHILGEVCREKQEAA	RASA3	321	Q14644
LSDQGLVVNDCHAEV	ADARB2	421	Q9NS39
CVSEEEALHLGAVLV	RGS11	66	O94810
AALLCVNAIAVLHEE	IER3IP1	11	Q9Y5U9
LFHVCEDLENIEGLH	PPP4R3A	176	Q6IN85
CIATHESNGIDIIIA	ITPR2	2006	Q14571
AACQLHGGLELEEET	KASH5	106	Q8N6L0
LEKCSDNDGIVHIAV	LEMD3	811	Q9Y2U8
LNHGTLQEAEIACLV	RNF144B	81	Q7Z419
QEEACAVILLEHGAN	ANKRD20A2P	111	Q5SQ80
HCLEDAADGKVQVLL	CFD	66	P00746
AGHCTVLVEVVDVND	PCDHA7	331	Q9UN72
GHCLVRVVAEELENV	FBXO22	81	Q8NEZ5
CQVEHSSALAVEELG	MINDY3	131	Q9H8M7
VGNSVCDILLALHTE	MDN1	2336	Q9NU22
LHGELLETCVVNIAL	MED13L	1846	Q71F56
ADVLCEFLEVAVHLI	MAD2L2	16	Q9UI95
EELVAEAHNLCTLLE	IKBKB	706	O14920
IDIAQEEVLTCLGIH	GGNBP2	291	Q9H3C7
EQGLELCRVVAVHVE	MYO15A	3496	Q9UKN7
VLSQLEACGLVETIH	MYO19	636	Q96H55
VHEDEILVGLCRVAI	NLRP11	326	P59045
CTAEIEHRALDVQGI	GMIP	571	Q9P107
LVEALQGHRVVDIAC	HERC2	4136	O95714
HVLEGQEVRLDCEAD	HMCN2	3236	Q8NDA2
CATAHIGGVNIVLLE	KIAA1109	2826	Q2LD37
GGLHVDLAQIIEACD	EIF3M	36	Q7L2H7
AVLHLQSAEELDCQG	CSRNP3	326	Q8WYN3
LCVEVADLVSILVHA	HR	1006	O43593
QCLAVEALAEEVGAL	HMGXB3	181	Q12766
AVLCHDGILVVEVKD	HSPB3	131	Q12988
QLVCLGESRAVEEHA	LTK	176	P29376
EIVHIECELNFEIHG	F13B	296	P05160
AIGCHVVNIGAEDLR	PLS3	206	P13797
HQTLLQGVVVLEEFC	FHIP2B	701	Q86V87
GEDAECHAAKLLEVI	IPO7	731	O95373
LCHAEVQVGDQLETV	KPTN	146	Q9Y664
DLAAHCSIQVEILDD	PCDHGB2	326	Q9Y5G2
EVEILAVIVGCLCHD	PDE11A	691	Q9HCR9
EGLHIDQLVCLVLEA	CUL7	1581	Q14999
EEVENNLLHLEDLCG	DTNBP1	126	Q96EV8
IHGENIICEATQIID	GDAP1	81	Q8TB36
ELLDVHAVCEREAIA	GBP7	351	Q8N8V2
LVGLFEDTNLCVIHA	H3-4	101	Q16695
EDARLCHILEEVAGL	LMNTD2	86	Q8IXW0
NTLDHTGVVVLCEAL	NLRP4	931	Q96MN2
GNLEHLECVTLDIEE	LRP2	1916	P98164
DLGQDVICSHTEGLI	MUC5AC	1636	P98088
VEELEHRCIQLSGET	GOLGA2	826	Q08379
DLEVCLEGHQVKLNA	PPFIBP2	141	Q8ND30
HIEAIECENLENLCV	LRRIQ1	851	Q96JM4
GVLEVLSEVECHLRV	NPHP4	46	O75161
IHVEGLNVCLENVIG	SBF1	156	O95248
IHEALLEAVGCGNTE	PTPRS	1641	Q13332
HLGDEVNLKVTVLCD	PIK3C2B	371	O00750
EVICQVLHLGTVTDF	CD200	211	P41217
AGHCTLLVEVLDVND	PCDHA13	331	Q9Y5I0
GHCTVLVELLDENDN	PCDHA10	331	Q9Y5I2
AGHCKVLVDIVDVND	PCDHAC2	346	Q9Y5I4
VAHVAGFLLEDRAVC	FZD7	301	O75084
CDLITDVALHEVVDL	EIF2B3	106	Q9NR50
QEEACAVILLEHGAN	ANKRD20A3P	111	Q5VUR7
HCDLAIKTVEEIEGV	MCC	201	P23508
LQHLETCLLQVVGEG	IFNW1	116	P05000
TISECLLHLQVQGEE	FAM124B	431	Q9H5Z6
HVIEVDEGNTAVIAC	BOC	136	Q9BWV1
LCGHDAVKEALVDQA	CYP2A13	81	Q16696
DCSDANDALIVLIHL	FBXO7	191	Q9Y3I1
LCGHDAVREALVDQA	CYP2A7	81	P20853
LCGILKNEVLEDHVQ	COG3	426	Q96JB2
LALECGNIEIALEAA	COPA	651	P53621
VVLLNGQHLEVKCDV	FRMPD2	346	Q68DX3
HAIGLSCELVVEHIQ	ARFGEF3	1531	Q5TH69
GLIHLEGDTVQIICN	CFHR5	101	Q9BXR6
RDNLEACISGLHVDV	DNAH14	836	Q0VDD8
QVLIGDVEDAICLHA	EDEM1	446	Q92611
QAVVGDLLELHCESL	FCRL3	486	Q96P31
DLVCIGLIVHEGAAV	MARCHF11	291	A6NNE9
LTCVELADAEVGLHV	CDH26	601	Q8IXH8
HQLEKVDGVLCLADI	INSC	316	Q1MX18
AQVLEGCIAEIHNIT	CARMIL1	471	Q5VZK9
LEGLQTSDVDIIRHC	COG2	216	Q14746
EEENLEDGIHLVVCV	FAM135B	1131	Q49AJ0
TGLVLDEQLNEFHCL	HDAC6	86	Q9UBN7
LDLRHCEVELVAEGA	CHADL	91	Q6NUI6
CADVLAEEGEVHVAL	FDXACB1	111	Q9BRP7
QDLLAHCGIQLDGEE	RYR1	2036	P21817
EASSGILEVLHCVLV	RYR2	566	Q92736
AVELAALCLQAELGE	EPB41L4B	201	Q9H329
CDGLVDALIFIVQAE	CTNND1	551	O60716
EEVDCLVLQLHRVGE	MIF4GD	146	A9UHW6
VCGDLHGQLDDLIFI	PPEF2	176	O14830
HDALLEAVTCGNTEV	PTPRD	1606	P23468
EELAVHLGFNLCAEE	PLA2G4D	276	Q86XP0
GEDAECHAAKLLEVI	IPO8	731	O15397
ICSLRDHEAVVGQLA	RNF186	96	Q9NXI6
LAELQKLGAEVEVCH	FAN1	991	Q9Y2M0
CIEEGHTDQLLEIIQ	GLMN	36	Q92990
ACILKHAVTGEAVEL	PRXL2B	11	Q8TBF2
ECHSAVIQAVEDLDL	UTP20	1071	O75691
GADEHLQLISLCATV	RFC4	341	P35249
SGHCALEAALVNVLE	AGXT	81	P21549
CNKGIEVLFAVALEH	TRMT1L	446	Q7Z2T5
LVECIGVEHILAIDK	THADA	461	Q6YHU6
LVDGCHRAAEGVQEV	SNTA1	396	Q13424
GISALHQACIDENLE	PPP1R12C	101	Q9BZL4
CAIVDGVFAARHIDL	TMEM255A	106	Q5JRV8
LGNGACAHDQLEVIE	FBXL20	346	Q96IG2
NAIDLVVAADVEHCE	LAMA1	696	P25391
LLGCEVDADQVILSH	HDHD5	106	Q9BXW7
HLISQCEQLEGEVGA	SMG1	2611	Q96Q15
FCEEQNTGILHDEIL	POTEJ	566	P0CG39
QDCRAEILHEIAVLE	STK17B	71	O94768
GQDTDIHVIALALEV	SHCBP1L	241	Q9BZQ2
IGVIAVVLATHLCDE	ST3GAL5	341	Q9UNP4
VLEGQSLHLVCAVDS	SIGLEC12	391	Q96PQ1
ADIIHACDIVEDAAI	FARSB	356	Q9NSD9
LLLQDCGVHVQVAEG	ACD	96	Q96AP0
REDQEHQGALVCLAE	ACD	176	Q96AP0
LCGLHIVIHADELEE	CLTCL1	1271	P53675
VTEEDVQLRHCLGVF	NCAPG	741	Q9BPX3
LACLEGAREESVHLV	CLEC16A	586	Q2KHT3
VFCLVAVHAVIGDEL	CLASP2	1241	O75122
IGHQELVLEAVDLLC	CNK3/IPCEF1	56	G9CGD6
VLCAAVELLHEADAL	CNKSR1	111	Q969H4
GHQELILEAVDLLCA	CNKSR2	61	Q8WXI2
IGHQELVLEAVDLLC	CNKSR3	56	Q6P9H4
NSIHFEGIVCQLDII	COL24A1	211	Q17RW2
CAVENEELVQHLGAA	TRAK1	301	Q9UPV9
AALHEAVLSGNLECV	PPP1R27	66	Q86WC6
GNELNITHELFDICL	TBC1D14	416	Q9P2M4
VVLLLGLLNEDDACH	RNF213	3561	Q63HN8
QHEEIIGKVCELINE	ZNF618	821	Q5T7W0
HLVGDCELSVVEILV	VPS13A	896	Q96RL7
GLHDDIALVQLAEEV	TMPRSS11B	266	Q86T26
KEVTLIEELHCAGQA	RIPOR3	786	Q96MK2
VAALIDEQILCVHGG	PPP6C	151	O00743
HLLLEVEVIEGTLQC	TRMT112	86	Q9UI30
DNEAITQEIVGCAHL	VTA1	76	Q9NP79
DCELQHRVEAIVAFG	RYR3	1816	Q15413
IIEVENLNHCEFALL	SEPTIN3	286	Q9UH03
IHVLIDGLVACVAQL	TRPC5OS	6	A6NMA1
GAHCVALVDQEASDL	SERPINA13P	16	Q6UXR4
ELLQDVCAGLAEELH	XDH	481	P47989
GIEHSLIEENCGVVV	VPS13C	2266	Q709C8
VIEACDELGIILAHT	ATIC	571	P31939
ALHIVTELCFAGQVE	SYT10	16	Q6XYQ8
LECLNAILIHGVDIT	UACA	81	Q9BZF9
VAELTGDHQLCKEEI	SNRNP200	566	O75643
ENSLHVVVNCGEALL	UBR3	491	Q6ZT12
TEEILVCGHSLEVNI	VPS13B	1716	Q7Z7G8
HVAIGADCERLSAQI	TCEA2	156	Q15560
VLCLQLSLDDHVVAV	WDR27	126	A2RRH5
ILVQGCHAAAELIKE	SNTB2	431	Q13425
CGNVAAILELDEHLQ	PPP4C	266	P60510
IEHVADVDTLLECVN	XRCC3	181	O43542
IIQDRVSLGDDVHDC	ZNF805	171	Q5CZA5
IGESHGINIICEIVD	ZFYVE16	586	Q7Z3T8
HILELLCEIVSANAE	GEMIN4	731	P57678
EDGILEANHVSTLAC	SLC8A1	506	P32418
EQQHKGIIAILDDAC	MYO1D	446	O94832
DNRVGELVGVLAAHC	MYO1G	951	B0I1T2
EGALLQCHQVVGVDV	EXD3	386	Q8N9H8
SLTVEDCVVHIDLNL	N4BP2	1401	Q86UW6